0 results for 'Novo Nordisk A/S'
Judge Shuts Down Efforts to Expand Scope of Discovery in Ozempic MDL
Judge Karen Marston held that, despite plaintiffs' arguments to the contrary, marketing discovery is not relevant to the broad legal issues the court has prioritized for early resolution.Ozempic Plaintiffs Push for Marketing Discovery After MDL Judge Imposes Limits
"These are not case-specific issues," the plaintiffs contended. "The marketing was national in scale and magnitude, and everything that occurred with regard to these drugs over the last several years is in some way tethered to the marketing."4 Law Firms Back Texas AG Suit on Insulin Price-Gouging Allegations
The state alleges this insulin pricing scheme violates the Texas Deceptive Trade Practices Act, constitutes unjust enrichment, and represents an unlawful civil conspiracy.FTC Takes Legal Action Against Three Largest PBMs Over High Insulin Prices
"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed," said Rahul Rao, deputy director of the FTC's Bureau of Competition.View more book results for the query "Novo Nordisk A/S"
Novo Nordisk Files Patent Claims to Fend off Generic Rivals of Wegovy
Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular weight-loss drug. Novo Nordisk says the efforts infringe on its patent.Fast-Growing Madrigal Pharma Names Veteran Health Care Lawyer Legal Chief
The Pennsylvania-based company promoted Shannon Kelley to her first general counsel post, just months after the successful launch of a drug to treat liver diseaseNovo Nordisk Seeks Patent Litigation Barrier to Ozempic Generic
The Ozempic manufacturer, represented in both cases by Fenwick & West, filed one complaint on Wednesday in the District of Delaware, then filed a nearly identical one in the Northern District of West Virginia.AstraZeneca Sues an Attorney General as Big Pharma Challenges Rise
"Exploiting a loophole in the federal 340B drug program—a program intended to benefit the needy—[pharmaceutical companies] have in recent years begun imposing their will on Mississippi medical providers and pharmacies," the defendant contended.Who Did Big Law's Top Lobbying Earners Pick Up As Clients in Q2?
Brownstein, Akin, Holland & Knight, Arnold & Porter, King & Spalding and Wilmer are among the firms that have filed new lobbying registrations.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Data Management and Analytics: The Key to Success for Legal Operations
Brought to you by DiliTrust
Download Now
Small Law Firm Playbook: The Expert's Guide to Getting the Most Out of Legal Software
Brought to you by PracticePanther
Download Now
Strong & Hanni Solves Storage Woes--Learn How You Can, Too
Brought to you by Filevine
Download Now
Meeting the Requirements of California's SB 553: Workplace Violence Prevention
Brought to you by NAVEX Global
Download Now